Peptide protein translation inhibitor and the use thereof for protein translation control
Référence
85498-01
Mots-clés
Statut des brevets
French Patent Application: FRO350357 filed on July 21st 2003, entitled “Peptide inhibiteur de la traduction des proteins et ses utilisations pour le contôle de la traduction des protéines”
Inventeurs
Bertrand COSSON
Luc PAILLARD
Vincent LEGAGNEUX
Howard OSBORNE
Statut commercial
Exclusive or non-exclusive licenses.
Laboratoire
Institut de Génétique et Développement de Rennes (IGDR, UMR6061), Rennes, France.
Description
TECHNICAL DESCRIPTION
The inventive peptide protein translation inhibitor is characterised in that the size thereof is greater than 250 amino acids and it comprises an amino acid sequence which is at least for 85% identical to an aminoacid sequence SEQ ID Ndeg.1.
Said invention also relates to a fusion polypeptide which specifically inhibits an interesting target polynucleotide translation which is characterised in that said polypeptide comprises the above defined inhibiting peptide fused with a RNA binding protein.
INDUSTRIAL APPLICATIONS
The principal industrial applications of the invention are the control of the production of proteins of interest as a bioreactor, the control of the production of proteins of interest in cellular therapy (somatic genic therapy) or the control of the production of viral proteins within the framework of antiviral therapies.
Besoin de plus d'informations ?
Nous contacterTechnologies Liées
-
07.06.2016
Novel recombinant lectins and applications for the detection of pathological state markers
Health / Therapeutic, Medical Diagnostic 06433-01
-
27.07.2015
A new class of compounds, inhibitors of advanced glycation end-products (AGE) formation, to prevent the deleterious effects of aging due to the formation of AGE
Health / Therapeutic, Other Technologies 01418-01
-
03.11.2014
New therapeutic peptide for Huntington’s Disease
Health / Therapeutic 04195-01